Literature DB >> 10844129

Changes in catecholaminergic pathways innervating the rat heart ventricle during morphine dependence. Involvement Of alpha(1)- and alpha(2)-adrenoceptors.

M V Milanés1, M L Laorden.   

Abstract

In the present study, we examined the effects of alpha(1)- and the alpha(2)-adrenoceptors blockade on the changes in the ventricular content of catecholamines in rats withdrawn from morphine. Rats were given morphine by s.c. implantation of morphine pellets for 5 days. On the seventh day, morphine withdrawal was induced by s.c. administration of naloxone (1 mg/kg), and rats were killed 30 min later. Pretreatment with yohimbine (alpha(2)-adrenoceptor) or prazosin (alpha(1)-adrenoceptor) 15 min prior to naloxone administration attenuated some of the behavioural signs of morphine withdrawal. In addition, biochemical analysis indicated that yohimbine completely abolished the withdrawal-induced increase in noradrenaline and dopamine turnover in the right ventricle. By contrast, prazosin did not block the hyperactivity of catecholaminergic neurons in the heart during withdrawal. These data suggest that the hyperactivity of catecholaminergic neurons in the heart during morphine withdrawal is dependent upon alpha(2)-adrenoceptor activation. In addition, the present results rule out the involvement of alpha(1)-adrenoceptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10844129     DOI: 10.1016/s0014-2999(00)00307-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  The effects of serotonin/norepinephrine reuptake inhibitors and serotonin receptor agonist on morphine analgesia and tolerance in rats.

Authors:  Ercan Ozdemir; Sinan Gursoy; Ihsan Bagcivan
Journal:  J Physiol Sci       Date:  2012-04-29       Impact factor: 2.781

2.  Differential involvement of 3', 5'-cyclic adenosine monophosphate-dependent protein kinase in regulation of Fos and tyrosine hydroxylase expression in the heart after naloxone induced morphine withdrawal.

Authors:  Pilar Almela; Manuela Cerezo; A González-Cuello; M Victoria Milanés; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-11-25       Impact factor: 3.000

3.  Activation of c-fos expression in the heart after morphine but not U-50,488H withdrawal.

Authors:  Ana González-Cuello; M Victoria Milanés; M Teresa Castells; M Luisa Laorden
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

4.  Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.

Authors:  Ana González-Cuello; M Victoria Milanés; Manuel Aviles; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-13       Impact factor: 3.000

5.  The PKs PKA and ERK 1/2 are involved in phosphorylation of TH at Serine 40 and 31 during morphine withdrawal in rat hearts.

Authors:  P Almela; Mv Milanés; Ml Laorden
Journal:  Br J Pharmacol       Date:  2008-06-09       Impact factor: 8.739

6.  Role of PKC in regulation of Fos and TH expression after naloxone induced morphine withdrawal in the heart.

Authors:  Pilar Almela; Manuela Cerezo; M Victoria Milanés; M Luisa Laorden
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-11       Impact factor: 3.000

7.  Activation of the ERK signalling pathway contributes to the adaptive changes in rat hearts during naloxone-induced morphine withdrawal.

Authors:  P Almela; M V Milanés; M L Laorden
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

8.  Effects of alpha 2-adrenoceptor agonists dexmedetomidine and guanfacine on morphine analgesia and tolerance in rats.

Authors:  Sinan Gursoy; Ercan Ozdemir; Ihsan Bagcivan; Ahmet Altun; Nedim Durmus
Journal:  Ups J Med Sci       Date:  2011-09-16       Impact factor: 2.384

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.